Works matching IS 20457634 AND DT 2023 AND VI 12 AND IP 11

Results: 76
    1

    A nurse‐led intervention in patients with newly diagnosed cancer and Type 2 diabetes: A pilot randomized controlled trial feasibility study.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 11, p. 12874, doi. 10.1002/cam4.6118
    By:
    • Scarton, Lisa;
    • Nelson, Tarah;
    • Jo, Ara;
    • O'Neal, LaToya J.;
    • Yao, Yingwei;
    • Huggins, Shavondra;
    • Legaspi, Anatolia B.;
    • McClaren, Mariah J.;
    • Cabassa, Jake S.;
    • Burgos Melendez, Joan M.;
    • Munoz‐Pena, Juan M.;
    • Markham, Merry J.;
    • Murphy, Martina C.;
    • Chatzkel, Jonathan A.;
    • Rogers, Sherise;
    • George, Thomas J.
    Publication type:
    Article
    2
    3
    4
    5
    6

    Pilot study of implementing the Shared Healthcare Actions & Reflections Electronic systems in Survivorship (SHARE‐S) program in coordination with clinical care.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 11, p. 12847, doi. 10.1002/cam4.5965
    By:
    • Sohl, Stephanie J.;
    • Sadasivam, Rajani S.;
    • Kittel, Carol;
    • Dressler, Emily V.;
    • Wentworth, Stacy;
    • Balakrishnan, Kavitha;
    • Weaver, Kathryn E.;
    • Dellinger, Rebecca Ann;
    • Puccinelli‐Ortega, Nicole;
    • Cutrona, Sarah L.;
    • Foley, Kristie L.;
    • Houston, Thomas
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Communication transforms the impact of the COVID‐19 pandemic on children with cancer and their families.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 11, p. 12813, doi. 10.1002/cam4.5950
    By:
    • Ferrara, Gia;
    • Aguina, Molly;
    • Mirochnick, Emily;
    • Wiphatphumiprates, Parima;
    • Moreira, Daniel C.;
    • Sniderman, Elizabeth;
    • Villegas, César A.;
    • Kaye, Erica C.;
    • Ragab, Iman;
    • Maliti, Biemba;
    • Naidu, Gita;
    • Gassant, Pascale Y.;
    • Arce, Daniela;
    • Arora, Ramandeep Singh;
    • Alcasabas, Ana Patricia;
    • Raza, Muhammad Rafie;
    • Velasco, Pablo;
    • Kambugu, Joyce;
    • Vinitsky, Anna;
    • Rodriguez Galindo, Carlos
    Publication type:
    Article
    21
    22
    23
    24
    25

    Low‐energy amplitude‐modulated electromagnetic field exposure: Feasibility study in patients with hepatocellular carcinoma.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 11, p. 12402, doi. 10.1002/cam4.5944
    By:
    • Capareli, Fernanda;
    • Costa, Frederico;
    • Tuszynski, Jack A.;
    • Sousa, Micelange C.;
    • Setogute, Yone de C.;
    • Lima, Pablo D.;
    • Carvalho, Luciana;
    • Santos, Elizabeth;
    • Gumz, Brenda P.;
    • Sabbaga, Jorge;
    • de Castria, Tiago B.;
    • Jardim, Denis L.;
    • Freitas, Daniela;
    • Horvat, Natally;
    • Bezerra, Regis O. F.;
    • Testagrossa, Leonardo;
    • Costa, Tiago;
    • Zanesco, Tatiana;
    • Iemma, Antonio F.;
    • Abou‐Alfa, Ghassan K.
    Publication type:
    Article
    26
    27
    28

    LY6K depletion modulates TGF‐β and EGF signaling.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 11, p. 12593, doi. 10.1002/cam4.5940
    By:
    • Park, Sujeong;
    • Park, Doyeon;
    • Han, Sora;
    • Chung, Ga Eun;
    • Soh, Sujung;
    • Ka, Hye In;
    • Joo, Hyun Jeong;
    • Yang, Young
    Publication type:
    Article
    29

    Disease progression status during initial immune checkpoint inhibitor (ICI) affects the clinical outcome of ICI retreatment in advanced non‐small cell lung cancer patients.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 11, p. 12388, doi. 10.1002/cam4.5939
    By:
    • Torasawa, Masahiro;
    • Yoshida, Tatsuya;
    • Takeyasu, Yuki;
    • Shimoda, Yukiko;
    • Tateishi, Akiko;
    • Matsumoto, Yuji;
    • Masuda, Ken;
    • Shinno, Yuki;
    • Okuma, Yusuke;
    • Goto, Yasushi;
    • Horinouchi, Hidehito;
    • Yamamoto, Noboru;
    • Takahashi, Kazuhisa;
    • Ohe, Yuichiro
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37

    The impact of curative conversion therapy aimed at a cancer‐free state in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 11, p. 12325, doi. 10.1002/cam4.5931
    By:
    • Shimose, Shigeo;
    • Iwamoto, Hideki;
    • Shirono, Tomotake;
    • Tanaka, Masatoshi;
    • Niizeki, Takashi;
    • Kajiwara, Masahiko;
    • Itano, Satoshi;
    • Yano, Yoichi;
    • Matsugaki, Satoru;
    • Moriyama, Etsuko;
    • Noda, Yu;
    • Nakano, Masahito;
    • Kuromatsu, Ryoko;
    • Koga, Hironori;
    • Kawaguchi, Takumi
    Publication type:
    Article
    38
    39
    40
    41
    42

    Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survival.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 11, p. 12272, doi. 10.1002/cam4.5925
    By:
    • Soares, Kevin C.;
    • Jolissaint, Joshua S.;
    • McIntyre, Sarah M.;
    • Seier, Kenneth P.;
    • Gönen, Mithat;
    • Sigel, Carlie;
    • Nasar, Naaz;
    • Cercek, Andrea;
    • Harding, James J.;
    • Kemeny, Nancy E.;
    • Connell, Louise C.;
    • Koerkamp, Bas Groot;
    • Balachandran, Vinod P.;
    • D'Angelica, Michael I.;
    • Drebin, Jeffrey A.;
    • Kingham, T. Peter;
    • Wei, Alice C.;
    • Jarnagin, William R.
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50